Read + Share
Andre T, Diaz LA Jr, Shiu KK. Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining
immune checkpoint inhibition with chemotherapy - Authors' reply. Lancet Oncol 2022;23:e246.
PMID: 35654063
|
 |
|
Andre T, Diaz LA Jr, Shiu KK. Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining
immune checkpoint inhibition with chemotherapy - Authors' reply. Lancet Oncol 2022;23:e246.
PMID: 35654063
|
|
|
|